Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs Meropenem in Complicated Intra-Abdominal Infections
NCT00229060Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of doripenem in Intra-abdominal infection (IAI), sponsored by Johnson & Johnson. Started Mar 2004; status: completed.
02
Drugs
doripenem
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00229060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229060.